BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21184787)

  • 1. Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes.
    Takano T; Tsukiyama-Kohara K; Hayashi M; Hirata Y; Satoh M; Tokunaga Y; Tateno C; Hayashi Y; Hishima T; Funata N; Sudoh M; Kohara M
    J Hepatol; 2011 Sep; 55(3):512-521. PubMed ID: 21184787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus NS3-4A protease regulates the lipid environment for RNA replication by cleaving host enzyme 24-dehydrocholesterol reductase.
    Tallorin L; Villareal VA; Hsia CY; Rodgers MA; Burri DJ; Pfeil MP; Llopis PM; Lindenbach BD; Yang PL
    J Biol Chem; 2020 Aug; 295(35):12426-12436. PubMed ID: 32641492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody 2-152a suppresses hepatitis C virus infection through betaine/GABA transporter-1.
    Satoh M; Saito M; Takano T; Kasama Y; Nishimura T; Nishito Y; Hirata Y; Arai M; Sudoh M; Kai C; Kohara M; Tsukiyama-Kohara K
    J Infect Dis; 2011 Oct; 204(8):1172-80. PubMed ID: 21917889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus promotes expression of the 3β-hydroxysterol δ24-reductase through Sp1.
    Saito M; Kohara M; Tsukiyama-Kohara K
    J Med Virol; 2012 May; 84(5):733-46. PubMed ID: 22431021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of 3β-hydroxysteroid-Δ24 Reductase (DHCR24) Expression Induced by Bovine Viral Diarrhea Virus Infection Facilitates Viral Replication via Promoting Cholesterol Synthesis.
    Ma Y; Han Y; Li Y; Fan W; Yao X; Huang X; Wang M; Jiang S; Zhao J; Qiao X; Song H; Xu Y
    J Virol; 2022 Dec; 96(24):e0149222. PubMed ID: 36468862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of Pycnogenol® on hepatitis C virus replication.
    Ezzikouri S; Nishimura T; Kohara M; Benjelloun S; Kino Y; Inoue K; Matsumori A; Tsukiyama-Kohara K
    Antiviral Res; 2015 Jan; 113():93-102. PubMed ID: 25446333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice.
    Nakagawa S; Umehara T; Matsuda C; Kuge S; Sudoh M; Kohara M
    Biochem Biophys Res Commun; 2007 Feb; 353(4):882-8. PubMed ID: 17196931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase.
    Nishimura T; Kohara M; Izumi K; Kasama Y; Hirata Y; Huang Y; Shuda M; Mukaidani C; Takano T; Tokunaga Y; Nuriya H; Satoh M; Saito M; Kai C; Tsukiyama-Kohara K
    J Biol Chem; 2009 Dec; 284(52):36442-36452. PubMed ID: 19861417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic polymorphisms in 3β-hydroxysterol Δ24-reductase promoter sequences.
    Salem NE; Saito M; Kasama Y; Ozawa M; Kawabata T; Harada S; Suda H; Asonuma K; El-Gohary A; Tsukiyama-Kohara K
    Microbiol Immunol; 2013 Mar; 57(3):179-84. PubMed ID: 23277918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3β-hydroxysterol δ24-reductase on the surface of hepatitis C virus-related hepatocellular carcinoma cells can be a target for molecular targeting therapy.
    Saito M; Takano T; Nishimura T; Kohara M; Tsukiyama-Kohara K
    PLoS One; 2015; 10(4):e0124197. PubMed ID: 25875901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo.
    Inoue K; Umehara T; Ruegg UT; Yasui F; Watanabe T; Yasuda H; Dumont JM; Scalfaro P; Yoshiba M; Kohara M
    Hepatology; 2007 Apr; 45(4):921-8. PubMed ID: 17393519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes.
    Katsume A; Tokunaga Y; Hirata Y; Munakata T; Saito M; Hayashi H; Okamoto K; Ohmori Y; Kusanagi I; Fujiwara S; Tsukuda T; Aoki Y; Klumpp K; Tsukiyama-Kohara K; El-Gohary A; Sudoh M; Kohara M
    Gastroenterology; 2013 Oct; 145(4):865-73. PubMed ID: 23791700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis.
    Di Stasi D; Vallacchi V; Campi V; Ranzani T; Daniotti M; Chiodini E; Fiorentini S; Greeve I; Prinetti A; Rivoltini L; Pierotti MA; Rodolfo M
    Int J Cancer; 2005 Jun; 115(2):224-30. PubMed ID: 15688385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seladin-1/DHCR24 Is Neuroprotective by Associating EAAT2 Glutamate Transporter to Lipid Rafts in Experimental Stroke.
    Hernández-Jiménez M; Martínez-López D; Gabandé-Rodríguez E; Martín-Segura A; Lizasoain I; Ledesma MD; Dotti CG; Moro MA
    Stroke; 2016 Jan; 47(1):206-13. PubMed ID: 26628388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.
    Liu WL; Yang HC; Hsu CS; Wang CC; Wang TS; Kao JH; Chen DS
    Proc Natl Acad Sci U S A; 2016 Dec; 113(51):14799-14804. PubMed ID: 27930338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Intracellular Cholesterol Transport Inhibitor U18666A Inhibits the Exosome-Dependent Release of Mature Hepatitis C Virus.
    Elgner F; Ren H; Medvedev R; Ploen D; Himmelsbach K; Boller K; Hildt E
    J Virol; 2016 Dec; 90(24):11181-11196. PubMed ID: 27707921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.
    Park HJ; Jeon EJ; Lee JS; Hong SH; Cho AN; Lee J; Moon JS; Jung KE; Oh JW; Lee H; Cho SW
    Adv Healthc Mater; 2016 Nov; 5(22):2931-2941. PubMed ID: 27774775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribonucleotide reductase M2 promotes RNA replication of hepatitis C virus by protecting NS5B protein from hPLIC1-dependent proteasomal degradation.
    Kitab B; Satoh M; Ohmori Y; Munakata T; Sudoh M; Kohara M; Tsukiyama-Kohara K
    J Biol Chem; 2019 Apr; 294(15):5759-5773. PubMed ID: 30755480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.